SNMMI 2020: Imaging highlights connection between heart and kidneys in heart attack response

Researchers have used whole-body PET imaging to highlight how the heart and kidneys respond together following a myocardial infarction (MI), sharing their findings at the Society of Nuclear Medicine and Molecular Imaging’s 2020 Annual Meeting.

The researchers noted that their study marks the first time medical imaging has been used to capture this specific response. They turned to 68Ga-pentixafor PET, imaging a total of 65 mice and tracking how each one responded to an induced MI after one day, three days, seven days and six weeks. A “clear correlation” between the responses of the heart and kidneys was detected and then confirmed using autoradiography.

In an SNMMI news release, Rudolf Werner, MD, PhD, a resident in the department of nuclear medicine at Hannover Medical School in Germany, said this work “provides an impetus for the pursuit of systems-based multi-organ imaging to investigate systemic response to focal injury.”

“Assessment of inflammation after myocardial infarction is beginning to be evaluated in clinical populations,” he added. “With the growth of long-bore cameras with larger fields of view, the concept of multi-organ imaging will expand substantially in the next years.”

The abstract to the team’s work is available here.

Find more SNMMI news

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.